Hypothesis

Chronic pain sensitivity reflects diminished Hedgehog (Shh) pathway activity in stromal and immune cells, which in turn drives inflammaging, epigenetic acceleration, and impaired tissue repair. Individuals with low pain thresholds exhibit reduced Shh signaling, leading to poorer regenerative outcomes and higher biological age as measured by DNAmGrimAge.

Mechanistic Rationale

• Pain processing is modulated by glial cells in the spinal dorsal horn; astrocytes and microglia release Shh that influences neuronal excitability and downstream inflammation (see glial activation in aging pain pathways)[https://www.frontiersin.org/journals/aging/articles/10.3389/fragi.2024.1477017/full].
• Shh signaling promotes mitochondrial biogenesis and attenuates NF‑κB–driven cytokine production in mesenchymal stromal cells, directly countering inflammaging.[https://doi.org/10.1007/s00018-015-1896-0]
• Declining Shh activity with age has been documented in muscle satellite cells and dermal fibroblasts, correlating with reduced proliferative capacity and delayed wound healing.[https://pmc.ncbi.nlm.nih.gov/articles/PMC8232903/]
• Therefore, a fall in Shh output could simultaneously heighten pain perception (via loss of inhibitory glial signaling) and accelerate epigenetic aging (via unchecked inflammatory signaling), while also impairing regenerative reserves.

Testable Predictions

1. Correlation: In a cohort of adults aged 40‑70, experimental heat pain threshold will inversely correlate with Shh pathway readouts (Gli1 mRNA, Ptch1 expression) isolated from peripheral blood mononuclear cells.
2. Causality: Pharmacological activation of Shh (e.g., SAG agonist) in aged mice will raise pain thresholds, lower DNAmGrimAge acceleration after a standardized inflammatory challenge, and improve muscle regeneration after cardiotoxin injury.
3. Intervention: Transcutaneous vagal nerve stimulation, known to increase pain tolerance, will upregulated Shh signaling in circulating monocytes, measurable within 2 h post‑stimulation.

Experimental Design

• Human arm: Recruit 120 participants, measure pain thresholds via quantitative sensory testing, collect blood for RNA‑seq (Gli1, Ptch1), and compute DNAmGrimAge. Use linear mixed models to test the pain‑Shh‑age triad.
• Mouse arm: Use 20‑month‑old C57BL/6 mice, administer SAG or vehicle for 2 weeks, then assess von Frey and Hargreaves tests, perform liver and muscle histology for regeneration markers (Ki67, Pax7), and extract DNA for epigenetic clock analysis.
• Mechanistic arm: Co‑culture dorsal horn astrocytes with neurons; manipulate Shh with CRISPRi/CRISPRa and evaluate neuronal firing and IL‑6 release.

Potential Implications

If validated, Shh activity could serve as a biomarker that bridges subjective pain experience with objective aging and regenerative health. Therapeutic strategies targeting the Hedgehog pathway—already explored in oncology and regenerative medicine—might be repurposed to improve pain tolerance, slow epigenetic aging, and enhance tissue repair in older populations.